Atovaquone
- Product NDC
- 0121-1016
- 11-digit product format
- 001211016
- Labeler code
- 0121
- Product ID
- 0121-1016_0145c97d-2d5e-4fcd-ae76-85e4ae946350
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atovaquone
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Application
- ANDA214272
- Marketing category
- ANDA
- Marketing start
- 2024-01-10
- Substance
- ATOVAQUONE
- Active strength
- 750 mg/5mL
- Pharmacologic classes
- Antimalarial [EPC], Antiprotozoal [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Atovaquone
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ATOVAQUONE | 750 mg/5mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | Y883P1Z2LT |
| Rxcui | 308429 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4a3a9d58-de64-b317-9153-f2c3fc3a43c9 | Product name | 8 | 20220517 |
| 7beb5026-9819-5e26-fae7-eca2788430de | Product name | 2 | 20150108 |
| 9869efd7-d6dd-0665-5b67-53adbe6ef15e | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0121-1016-05 | Atovaquone | 5 mL in 1 CUP, UNIT-DOSE | SUSPENSION | 5 | 13 | |
| 0121-1016-18 | Atovaquone | 6 in 1 TRAY | SUSPENSION | 6 | 13 | |
| 0121-1016-18 | Atovaquone | 3 in 1 CASE | SUSPENSION | 3 | 13 | |
| 0121-1016-42 | Atovaquone | 6 in 1 TRAY | SUSPENSION | 6 | 13 | |
| 0121-1016-42 | Atovaquone | 7 in 1 CASE | SUSPENSION | 7 | 13 | |
| 0121-1016-05 | Atovaquone | 5 mL in 1 CUP, UNIT-DOSE | SUSPENSION | 5 | 4 | |
| 0121-1016-18 | Atovaquone | 3 in 1 CASE | SUSPENSION | 3 | 4 | |
| 0121-1016-18 | Atovaquone | 6 in 1 TRAY | SUSPENSION | 6 | 4 | |
| 0121-1016-42 | Atovaquone | 7 in 1 CASE | SUSPENSION | 7 | 4 | |
| 0121-1016-42 | Atovaquone | 6 in 1 TRAY | SUSPENSION | 6 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0121-1016-05 | ML - Milliliter | 0121-1016 | 9865d66d-14b0-4346-aaaa-e329fddf1955 | 1 | 2024-02-14 |
| 0121-1016-18 | ML - Milliliter | 0121-1016 | 7b463db3-7c8c-455a-b126-c94f66f19ef1 | 1 | 2024-02-14 |
| 0121-1016-42 | ML - Milliliter | 0121-1016 | 39aab3ee-2ada-4bbf-8ca2-59a453d4fdf8 | 1 | 2024-02-14 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 308429 | atovaquone 750 MG in 5 mL Oral Suspension | PSN | df6086d3-6100-422a-bf23-e9610027749b | 13 |
| 308429 | atovaquone 150 MG/ML Oral Suspension | SCD | df6086d3-6100-422a-bf23-e9610027749b | 13 |
| 308429 | atovaquone 1500 MG per 10 ML Oral Suspension | SY | df6086d3-6100-422a-bf23-e9610027749b | 13 |
| 308429 | atovaquone 750 MG per 5 ML Oral Suspension | SY | df6086d3-6100-422a-bf23-e9610027749b | 13 |
| 308429 | atovaquone 750 MG in 5 mL Oral Suspension | PSN | 2a7b2c9c-dbdd-41a8-a0eb-e3af4d8212be | 4 |
| 308429 | atovaquone 150 MG/ML Oral Suspension | SCD | 2a7b2c9c-dbdd-41a8-a0eb-e3af4d8212be | 4 |
| 308429 | atovaquone 1500 MG per 10 ML Oral Suspension | SY | 2a7b2c9c-dbdd-41a8-a0eb-e3af4d8212be | 4 |
| 308429 | atovaquone 750 MG per 5 ML Oral Suspension | SY | 2a7b2c9c-dbdd-41a8-a0eb-e3af4d8212be | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0121-1016-05 | 00121101605 | 5 mL in 1 CUP, UNIT-DOSE | 5 ml | Historical | |||
| 0121-1016-18 | 00121101618 | 3 TRAY in 1 CASE (0121-1016-18) / 6 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-1016-05) | 3 tray | 2024-01-10 | No | No | Current |
| 0121-1016-42 | 00121101642 | 7 TRAY in 1 CASE (0121-1016-42) / 6 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-1016-05) | 7 tray | 2024-01-10 | No | No | Current |